![Iain Wilcock](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Iain Wilcock
Directeur/Membre du Conseil chez
Oxxon Therapeutics, Inc.
Profil
Iain Charles Wilcock is currently Secretary & Director at Brathew Ltd., Non-Executive Director at Oxxon Therapeutics, Inc., Director at Kebony AS, Director at Microbiotica Ltd., and Venture Partner at Seventure Partners since 2008.
Former roles include Investment Director at Nesta Investment Management LLP from 2008 to 2010, Director at Vivostat A, Director at Xention Pharma Ltd., Director at Lectus Therapeutics Ltd., Deputy Managing Director at SPARK Venture Management Ltd. from 2004 to 2007, Director at Avidex Ltd., Director at Ipsen Bioinnovation Ltd., and.
Director at PhosphonicS Ltd. Education includes an undergraduate degree from the University of Oxford, conferred in 1985.
Postes actifs de Iain Wilcock
| Sociétés | Poste | Début |
|---|---|---|
Oxxon Therapeutics, Inc.
 Oxxon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures antigen-specific immunotherapy’s to treat patients | Directeur/Membre du Conseil | - |
Kebony AS
 Kebony AS Forest ProductsNon-Energy Minerals Provides wooden products and processing | Directeur/Membre du Conseil | - |
Microbiotica Ltd.
 Microbiotica Ltd. BiotechnologyHealth Technology Operates research and experimental development on biotechnology | Directeur/Membre du Conseil | - |
Brathew Ltd.
 Brathew Ltd. Engineering & ConstructionIndustrial Services Develops building projects | Directeur/Membre du Conseil | 21/07/2012 |
Anciens postes connus de Iain Wilcock
| Sociétés | Poste | Fin |
|---|---|---|
Nesta Investment Management LLP
 Nesta Investment Management LLP Investment ManagersFinance Nesta Investments invests in companies located in the United Kingdom. The firm targets companies operating across a broad range of sectors and industries. It provides financing for seed and early stage capital requirements with an investment size ranging from GBP 0.15 to 2 million and also makes follow-on investments. | Private Equity Investor | 01/01/2010 |
Avidex Ltd.
 Avidex Ltd. Pharmaceuticals: MajorHealth Technology Develops and discovers drugs for the treatment of cancer and autoimmune diseases | Directeur/Membre du Conseil | 04/12/2008 |
SPARK Venture Management Ltd.
 SPARK Venture Management Ltd. Investment ManagersFinance SPARK Ventures invests in companies located in the United Kingdom. The firm focuses on a broad range of sectors and industries. It provides financing for early stage capital requirements. | Head-Equity Investments | 01/03/2007 |
Vivostat A/S
 Vivostat A/S Medical SpecialtiesHealth Technology Manufactures and distributes systems for on-site preparation & application of autologous concentrated fibrin and platelet enriched fibrin sealants | Directeur/Membre du Conseil | - |
PhosphonicS Ltd.
 PhosphonicS Ltd. BiotechnologyHealth Technology Develops products for separation and purification of solid materials | Directeur/Membre du Conseil | - |
Formation de Iain Wilcock
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
91
Relations au 1er degré
13
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 13 |
|---|---|
University of Oxford
 University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
SPARK Venture Management Ltd.
SPARK Venture Management Ltd. Investment ManagersFinance SPARK Ventures invests in companies located in the United Kingdom. The firm focuses on a broad range of sectors and industries. It provides financing for early stage capital requirements. | Finance |
Xention Pharma Ltd.
 Xention Pharma Ltd. Pharmaceuticals: MajorHealth Technology Develops and researches drugs | Health Technology |
Avidex Ltd.
Avidex Ltd. Pharmaceuticals: MajorHealth Technology Develops and discovers drugs for the treatment of cancer and autoimmune diseases | Health Technology |
Lectus Therapeutics Ltd.
 Lectus Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Developed ion channel modulators and therapeutics | Health Technology |
Oxxon Therapeutics, Inc.
Oxxon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures antigen-specific immunotherapy’s to treat patients | Health Technology |
Vivostat A/S
Vivostat A/S Medical SpecialtiesHealth Technology Manufactures and distributes systems for on-site preparation & application of autologous concentrated fibrin and platelet enriched fibrin sealants | Health Technology |
Nesta Investment Management LLP
Nesta Investment Management LLP Investment ManagersFinance Nesta Investments invests in companies located in the United Kingdom. The firm targets companies operating across a broad range of sectors and industries. It provides financing for seed and early stage capital requirements with an investment size ranging from GBP 0.15 to 2 million and also makes follow-on investments. | Finance |
PhosphonicS Ltd.
PhosphonicS Ltd. BiotechnologyHealth Technology Develops products for separation and purification of solid materials | Health Technology |
Kebony AS
Kebony AS Forest ProductsNon-Energy Minerals Provides wooden products and processing | Non-Energy Minerals |
Microbiotica Ltd.
Microbiotica Ltd. BiotechnologyHealth Technology Operates research and experimental development on biotechnology | Health Technology |
Ipsen Bioinnovation Ltd.
 Ipsen Bioinnovation Ltd. BiotechnologyHealth Technology Engages in research and experimental development on biotechnology | Health Technology |
Brathew Ltd.
Brathew Ltd. Engineering & ConstructionIndustrial Services Develops building projects | Industrial Services |
